feed,title,long_url,short_url
BioRxiv,SARS-CoV-2 Omicron Spike Glycoprotein Receptor Binding Domain Exhibits Super-Binder Ability with ACE2 but not Convalescent Monoclonal Antibody,https://biorxiv.org/cgi/content/short/2021.12.09.471885v1?rss=1,https://j.mp/3EJGU9E
BioRxiv,Nanotrap Particles Improve Nanopore Sequencing of SARS-CoV-2 and Other Respiratory Viruses,https://biorxiv.org/cgi/content/short/2021.12.08.471814v1?rss=1,https://j.mp/3DBtsmM
BioRxiv,"A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection",https://biorxiv.org/cgi/content/short/2021.12.07.471590v1?rss=1,https://j.mp/3ycKV3S
BioRxiv,Structural Insights of SARS-CoV-2 Spike Protein from Delta and Omicron Variants,https://biorxiv.org/cgi/content/short/2021.12.08.471777v1?rss=1,https://j.mp/31CBnn7
BioRxiv,A Graph Convolutional Network-based screening strategy for rapid identification of SARS-CoV-2 cell-entry inhibitors,https://biorxiv.org/cgi/content/short/2021.12.08.471787v1?rss=1,https://j.mp/3IOaFZt
BioRxiv,Mutations in the spike RBD of SARS-CoV-2 omicron variant may increase infectivity without dramatically altering the efficacy of current multi-dosage vaccinations,https://biorxiv.org/cgi/content/short/2021.12.08.471688v1?rss=1,https://j.mp/3lRR0xU
BioRxiv,Deep Mutational Engineering of broadly-neutralizing and picomolar affinity nanobodies to accommodate SARS-CoV-1 & 2 antigenic polymorphism,https://biorxiv.org/cgi/content/short/2021.12.07.471597v1?rss=1,https://j.mp/3yb5626
BioRxiv,"Orally administered epeleuton inhibits SARS-CoV-2 viral load, replication and pathology in the Syrian Hamster model",https://biorxiv.org/cgi/content/short/2021.12.07.471588v1?rss=1,https://j.mp/3dTpL1z
BioRxiv,Combinatorial mRNA vaccination enhances protection against SARS-CoV-2 delta variant,https://biorxiv.org/cgi/content/short/2021.12.08.471664v1?rss=1,https://j.mp/3dDsbkx
BioRxiv,B.1.1.529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes,https://biorxiv.org/cgi/content/short/2021.12.07.470392v1?rss=1,https://j.mp/33j89tR
BioRxiv,Simultaneous analysis of antigen-specific B and T cells after SARS-CoV-2 infection and vaccination,https://biorxiv.org/cgi/content/short/2021.12.08.471684v1?rss=1,https://j.mp/3pMYt2j
